Read the full article here.
This content was originally published by BusinessLIVE. Original publishers retain all rights. It appears here for a limited time before automated archiving. By BusinessLIVE
The commission had begun an investigation in 2017 amid concerns of excessive pricing for some cancer drugs, and is now requesting feedback